Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 22, Issue 4, Pages 376-383
Publisher
Wiley
Online
2014-09-15
DOI
10.1111/jvh.12311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 648 Low Treatment Rates and Suboptimal Treatment Completion Rates to Hepatitis C Virus (HCV) Therapy: A Real-World Analysis of a Large US Cohort
- (2014) Philip Vutien et al. GASTROENTEROLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 845 ONCE DAILY SOFOSBUVIR PLUS RIBAVIRIN FOR 12 AND 24 WEEKS IN TREATMENT-NAÏVE PATIENTS WITH HCV INFECTION: THE QUANTUM STUDY
- (2013) J.P. Lalezari et al. JOURNAL OF HEPATOLOGY
- 49 LIFETIME COSTS ATTRIBUTABLE TO CHRONIC HEPATITIS C FROM THE FRENCH HEALTHCARE PERSPECTIVE (ANRS N°12188)
- (2013) M. Schwarzinger et al. JOURNAL OF HEPATOLOGY
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
- (2013) Kris V Kowdley et al. LANCET
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse
- (2013) Martin Lagging et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials
- (2012) L. Y. Lee et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon- for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial
- (2012) P. Labarga et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C
- (2012) Xin Gao et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003–2007)
- (2011) Marc Bourlière et al. ANTIVIRAL THERAPY
- Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis
- (2011) Sylvie Deuffic-Burban et al. GUT
- Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection
- (2011) Priscilla C Hsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 122 HCV BURDEN IN EUROPE: IMPACT OF NATIONAL TREATMENT PRACTICES ON FUTURE HCV-RELATED MORBIDITY AND MORTALITY THROUGH A MODELING APPROACH
- (2011) S. Deuffic-Burban et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study
- (2011) Patrick Marcellin et al. LIVER INTERNATIONAL
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication
- (2010) Lauren A. Beste et al. Clinical Gastroenterology and Hepatology
- Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in ‘true life’
- (2010) Alexandre Pariente et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors
- (2010) Christine Meffre et al. JOURNAL OF MEDICAL VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now